Aldeyra Therapeutics, Inc.
INJECTABLE FORMULATIONS
Last updated:
Abstract:
The present disclosure relates to therapeutic compounds and formulations for treating, reducing the risk of, or for preventing a disease, disorder, or condition characterized by the presence of toxic aldehydes.
Status:
Application
Type:
Utility
Filling date:
5 Dec 2019
Issue date:
5 May 2022